Pediatric Neurology
Volume 41, Issue 1 , Pages 17-21 , July 2009

Proinflammatory Plasma Cytokines in Children With Migraine

  • Leszek Boćkowski, MD

      Affiliations

    • Department of Pediatric Neurology and Rehabilitation, Medical University of Białystok, Białystok, Poland
    • Corresponding Author InformationCommunications should be addressed to: Dr. Boćkowski; Department of Pediatric Neurology and Rehabilitation; Medical University of Białystok; Waszyngton Street 17; 15-274 Białystok, Poland.
    • ,
  • Wojciech Sobaniec, MD

      Affiliations

    • Department of Pediatric Neurology and Rehabilitation, Medical University of Białystok, Białystok, Poland
    • ,
  • Beata Żelazowska-Rutkowska, MD

      Affiliations

    • Department of Pediatric Laboratory Diagnostics, Medical University of Białystok, Białystok, Poland

Received 12 September 2008 ,Accepted 4 February 2009.

References 

  1. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population based studies. Neurology. 1994;44(Suppl. 4):S17–S23
  2. Kemper RHA, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia. 2001;21:549–557
  3. Munno I, Centonze V, Marinaro M, et al. Cytokines and migraine: increase of IL-5 and IL-4 plasma levels. Headache. 1998;38:465–467
  4. Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ. The impact of migraine on quality of life in the general population: the GEM study. Neurology. 2000;55:624–629
  5. Mortimer MJ, Kay J, Gawkrodger DJ, Jaron A, Barker DC. The prevalence of migraine in atopic children: an epidemiological study in general practice. Headache. 1993;33:427–431
  6. Chabriat H, Danchot J, Michel P, Joire JE, Henry P. Precipitating factors of headache: a prospective study in a national control-matched survey in migraineurs and nonmigraineurs. Cephalalgia. 1999;39:335–338
  7. Covelli V, Massari F, Conrotto L, et al. Demonstration of an elevated frequency of infectious events in patients with migraine without aura: a correlation with their altered immune status. Eos J Immunol Immunopharmacol. 1993;13:173–175
  8. Mavromichalis I, Zaramboukas T, Giala MM. Migraine of gastrointestinal origin. Eur J Pediatr. 1995;154:406–410
  9. Perini F, D'Andrea G, Galloni E, et al. Plasma cytokine levels in migraineurs and controls. Headache. 2005;45:926–931
  10. Empl M, Sostak P, Riedel M. Decreased sTNF-RI in migraine patients?. Cephalalgia. 2003;23:55–58
  11. Mueller L, Gupta AK, Stein TP. Deficiency of tumor necrosis factor α in a subclass of menstrual migraineurs. Headache. 2001;41:129–137
  12. Munno I, Marinaro M, Bassi A, Cassiano MA, Causarano V, Centoze V. Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Headache. 2001;41:764–767
  13. Covelli V, Munno I, Pellegrino NM. Are TNF-α and IL-1β relevant in the pathogenesis of migraine without aura?. Acta Neurol (Napoli). 1991;13:205–211
  14. Van Hilten JJ, Ferrari MD, van der Meer JW, Gijsman HJ, Looij BJ. Plasma interleukin-1, tumour necrosis factor and hypothalamic–pituitary–adrenal axis responses during migraine attacks. Cephalalgia. 1991;11:65–67
  15. Headache Classification Committee; International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Second edition. Cephalalgia. 2004;24(Suppl. 1):8–160
  16. Gergont A, Kaciński M, Steczkowska-Klucznik M. Selected cytokines in children with idiopathic headache [Wybrane cytokiny u dzieci z samoistnymi bólami głowy. In Polish]. Neurologia Dziecięca. 2005;13:48;(abstract)
  17. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658–660
  18. Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF. Mechanisms of tumor necrosis factor-α (TNF-α) hyperalgesia. Brain Res. 1995;692:244–250
  19. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. Br J Pharmacol. 1992;107:660–664
  20. Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumour necrosis factor-α induces ectopic activity in nociceptive primary afferent fibres. Neuroscience. 1997;81:255–262
  21. Gallai V, Sarachielli P, Floridi A, Franceschini M, Trequattrini A, Firenze C. Monocyte function in migraine patients with and without aura. Headache Q. 1994;5:214–227
  22. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A. 1991;88:9292–9296
  23. Godfried MH, Van der Poll T, Jansen J, et al. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS. 1993;7:33–36
  24. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev. 1996;7:231–240
  25. Aggarwal BB, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw. 1996;7:93–124
  26. Osnes LTN, Foss KB, Joø GB, et al. Acetylsalicylic acid and sodium salicylate inhibit LBS-induced NF-κB/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alpha (TNF-α) in human monocytes. Thromb Haemost. 1996;76:970–976
  27. Shackelford RE, Alford PB, Xue Y, Thai SF, Adams DO, Pizzo S. Aspirin inhibits tumor necrosis factor-α gene expression in murine tissue macrophages. Mol Pharmacol. 1997;52:421–429
  28. Endres S, Whitaker RED, Ghorbani R, Meydani SN, Dinarello SA. Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1β and of tumor necrosis factor-α ex vivo. Immunology. 1996;87:264–270
  29. González E, de la Cruz C, de Nicoläs R, Egido J, Herrero-Beaumont G. Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions. 1994;41:171–178
  30. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw. 1994;5:517–531
  31. Rainero I, Pinessi L, Salani G, et al. A polymorphism in the interleukin-1α gene influences the clinical features of migraine. Headache. 2002;42:337–340
  32. Sarchielli P, Alberti A, Vaianella L, et al. Chemokine levels in the jugular venous blood of migraine without aura patients during attacks. Headache. 2004;44:961–968

PII: S0887-8994(09)00072-1

doi: 10.1016/j.pediatrneurol.2009.02.001

Pediatric Neurology
Volume 41, Issue 1 , Pages 17-21 , July 2009

Article Tools